Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Reuters NewMedia - October 28, 2005
Big companies, which run successful in-house HIV/AIDS testing and treatment facilities and pay for their workers' life-prolonging drugs, have teamed up with the World Economic Forum (WEF) to try to offer similar care to smaller businesses.
The smaller firms, which supply them with various services and products, have been found to have little if any formal ways of coping with AIDS, yet they employ the bulk of workers in Africa's biggest economy, officials said.
South African unit of carmaker Volkswagen, Unilever and state power utility Eskom are among the companies working with WEF's Global Health Initiative to try to expand HIV/AIDS care to their suppliers.
"Without our suppliers, we simply wouldn't be able to function," said Penny Mkalipe, Eskom's Health & Wellness head.
The project, which will see the big companies finance AIDS testing, counseling, awareness campaigns and treatment of infected workers in the smaller businesses, would be assessed in early 2006 to determine its impact, said Francesca Boldrini, Director of the WEF's Global Health Initiative.
Small and medium-sized firms provide more than 55 percent of all South African jobs, the African Development Bank has said.
The country struggles with the world's biggest caseload of HIV/AIDS in the world with about 6.5 million out of a population of around 47 million people infected.
Only half of small business owners in the country had a formal strategy to tackle AIDS, and over a third of those had no one to oversee the policy, the Grant Thornton 2005 Business Owners Survey issued in April showed.
051028
RE051030
Copyright © 2005 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .